Frequency Therapeutics, Inc.

Frequency Therapeutics, Inc.verified

FREQ

Price:

$0.2996

Market Cap:

$405.65M

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement...[Read more]

Industry

Biotechnology

IPO Date

2019-10-03

Stock Exchange

NASDAQ

Ticker

FREQ

The Current Ratio as of December 2024 (TTM) for Frequency Therapeutics, Inc. (FREQ) is 11.23

According to Frequency Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 11.23. This represents a change of -3.53% compared to the average of 11.64 of the last 4 quarters.

Frequency Therapeutics, Inc. (FREQ) Historical Current Ratio (quarterly & annually)

How has FREQ Current Ratio performed in the past?

The mean historical Current Ratio of Frequency Therapeutics, Inc. over the last ten years is 10.25. The current 11.23 Current Ratio has changed 10.86% with respect to the historical average. Over the past ten years (40 quarters), FREQ's Current Ratio was at its highest in in the June 2021 quarter at 19.09. The Current Ratio was at its lowest in in the September 2019 quarter at 2.31.

Quarterly (TTM)
Annual

Average

10.25

Median

8.45

Minimum

4.19

Maximum

24.20

Frequency Therapeutics, Inc. (FREQ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Frequency Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 186.40%

Maximum Annual Current Ratio = 24.20

Minimum Annual Increase = -72.89%

Minimum Annual Current Ratio = 4.19

Quarterly (TTM)
Annual
YearCurrent RatioChange
20238.8735.14%
20226.56-72.89%
202124.20186.40%
20208.45101.49%
20194.19-63.15%
201811.3841.02%

Frequency Therapeutics, Inc. (FREQ) Average Current Ratio

How has FREQ Current Ratio performed in the past?

The current Current Ratio of Frequency Therapeutics, Inc. (FREQ) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

13.21

5-year avg

10.45

10-year avg

10.25

Frequency Therapeutics, Inc. (FREQ) Current Ratio vs. Peers

How is FREQ’s Current Ratio compared to its peers?

Frequency Therapeutics, Inc.’s Current Ratio is greater than Lineage Cell Therapeutics, Inc. (2.48), greater than MAIA Biotechnology, Inc. (2.56), greater than Armata Pharmaceuticals, Inc. (0.19), greater than Portage Biotech Inc. (3.08), less than PMV Pharmaceuticals, Inc. (13.98), greater than Olema Pharmaceuticals, Inc. (7.10), greater than Enochian Biosciences, Inc. (0.08), greater than Scholar Rock Holding Corporation (3.88), greater than Passage Bio, Inc. (5.15), greater than Shattuck Labs, Inc. (7.96), greater than C4 Therapeutics, Inc. (6.31), less than Eliem Therapeutics, Inc. (0), greater than Prelude Therapeutics Incorporated (7.04), greater than Monte Rosa Therapeutics, Inc. (6.03), less than Absci Corporation (0), greater than Adverum Biotechnologies, Inc. (5.63), greater than Kezar Life Sciences, Inc. (5.82), greater than Oncternal Therapeutics, Inc. (7.65), greater than null (2.39),

Build a custom stock screener for Frequency Therapeutics, Inc. (FREQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Frequency Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Frequency Therapeutics, Inc. (FREQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Frequency Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Frequency Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Frequency Therapeutics, Inc. (FREQ)?

What is the highest Current Ratio for Frequency Therapeutics, Inc. (FREQ)?

What is the 3-year average Current Ratio for Frequency Therapeutics, Inc. (FREQ)?

What is the 5-year average Current Ratio for Frequency Therapeutics, Inc. (FREQ)?

How does the current Current Ratio for Frequency Therapeutics, Inc. (FREQ) compare to its historical average?